Intel Capital was among the participants in a round that lifted the total raised by rare disease-focused drug developer Healx to nearly $70m.

Boehringer Ingelheim Venture Fund co-led a $13.3m round for the immuno-oncoclogy startup, which was spun out of University of Duisburg-Essen’s and University of Düsseldorf.

Atomico has led $56m series B round for Cambridge-allied rare disease therapy developer Healx, which also welcomed Intel Capital as a new shareholder.

Neil Woodford has been removed as investment manager of the Equity Income Fund, which will be wound down by administrator Link Fund Solutions.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Ahren Innovation Capital has led a $16m initial series A tranche for Mogrify, co-founded by researchers from Bristol, Monash and Duke universities.

Ericsson Ventures contributed to a series A round for environmentally-friendly logistics technology provider Einride that will support US growth.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Existing investor Tencent is in talks as part of a round TUM's flying car developer reportedly aims to close at between $400m and $500m.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.